Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth 
FTC Questions Apple News Over Alleged Bias Against Conservative Media 
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid 
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims 
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle 
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems 
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains 
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth 
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App 
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed 
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 
How Marco Pharma International Preserves German Homeopathic Traditions in America 
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease 
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy 
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute 
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase 
Hong Kong, April 19, 2018 -- Dragon Jade International Limited (OTCQX: DGJI),a developer and marketer of next generation herbal and nutritional products and a supplier of medical devices and related services, today announcedthe initiation of a healthcare training division to address the growing opportunity the company believes exists in China as a result of the announcement in October of 2016 of Healthy China 2030.
The Healthy China 2030program is extending healthcare facilities from China’s largest cities to the entire nation’s population of 1.4 billion. Due to the rapid expansion of the healthcare sector, the company believes skill shortages are intensifying, as the existing level of trained staff and training facilities struggle to keep up with the rate of expansion.
Service providers globally have sought to access the opportunity to provide trained staff and training. The language barrier, cultural differences and the sheer size of the market have limited the abilities of such international service providers to address the market.
Dragon Jade is launching this new business to provide training and staffing to the Chinese healthcare market. The Company will utilize its access to medical professionals, experienced in both Western and Chinese medicine, from Hong Kong and Taiwan, who possess the necessary language and cultural skills to provide staffing solutions to the increasing numbers of China’s healthcare facilities. The Company plans to run specialist classes and training courses with support from its network of industry experts. Further, the Company will act as a conduit for well-known foreign medical schools and healthcare institutions to bring their procedures and products into the Chinese market.
Dragon Jade is in negotiations to use a facility in Guangdong Province, in southern China, as its first training center. Dragon Jade is in discussions with various other centers and potential partners in different locations in China to launch additional training centers. The centers are intended to be a platform for the Company to showcase its products and services in China.
Additionally, Dragon Jade is exploring remote training options, including virtual and augmented reality systems, which would enable training of larger numbers of people in more distant locations, using fewer teachers.
Dr. Steve Lai, CEO of the Company, commented: “The opportunity to provide both basic and advanced medical training in China will continue to grow as healthcare is rolled out across China, and as the expectations and ability to pay for better and more specialist treatment increases.”
About Dragon Jade
Dragon Jade International Limited (OTCQX: DGJI) is an Asian headquartered international healthcare group. With significant experience and contacts in the Greater China healthcare sector, the Group is focused on identifying, developing and marketing products from around the world in the Greater China market, and applying its international experience, network and access to experts, products and services in the fast-growing China market.
The Group has a particular strength in next generation herbal and natural products, leveraging proven resources to enhance and realize the commercial potential of herbal and biotechnological discoveries. The Group continues to develop, partner with and seek out cost-effective healthy living products.
Safe Harbor Statement
This release includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as the Company "believes," "expects," "anticipates," "foresees," "estimates," or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions, or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Contact: Investor Relations: PCG Advisory Group P: +1 646.863.7997 Corporate Relations Department Dragon Jade International [email protected] (+852) 2695-6999 www.dgjigroup.com
